Vnitr Lek 2005, 51(10):1079-1086

Comparison of catheterisation and surgical treatment of ostium secundum type atrial septal defect in adult patients

P. Růžička1,*, P. Malík1, J. Černý1, D. Kučera2, M. Homza2, P. Kala3, T. Brychta3
1 Centrum kardiovaskulární a transplantační chirurgie, Brno, ředitel prof. MUDr. Jan Černý, CSc.
2 Centrum vaskulárních intervencí Vítkovické nemocnice bl. Marie Antoníny, Ostrava-Vítkovice, přednosta prim MUDr. Miroslav Homza
3 Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jindřich Špinar, CSc., FESC

The authors compared rertrospectively feasibility, efficacy, safety and mid-term results of transcatheter and surgical treatment of isolated ostium secundum atrial septal defect in adult patients. Transcatheter closure was performed in 32 patients and surgical closure in 39 patients. Both methods were well matched in feasibility (97 % vs 100 %; NS) and in the incidence of major complications (0.0 % vs 2.6 %; NS). There were fewer minor complications (9.4 % vs 59.0 %; p < 0.001) and shorter hospital stay (3.3 ± 1.3 days vs 12.6 ± 4.5 days; p < 0.001) but higher costs (206 ± 22 vs 129 ± 55 thousand Czech Crowns; p < 0.001) in the device group. No patient had a hemodynamically significant residual shunt on discharge. Trivial residual shunt was more frequent in the device group (25.0 % vs 5.1 %; p < 0.05), however, the difference was not significant after 12 months of follow-up (6.3 % vs 5.1 %; NS). There was a significant improvement in functional NYHA class after 12 months by comparison with the condition before intervention (transcatheter closure before/after: 1.9 ± 0.6 vs 1.2 ± 0.3; p < 0.001, surgical closure before/after: 2.0 ± 0.7 vs 1.3 ± 0.5; p < 0.001) and the size of right ventricle also diminished significantly (transcatheter closure before/after: 40.0 ± 4.8 mm vs 30.0 ± 2.1 mm; p < 0.001), surgical closure before/after: 38.2 ± 5.3 mm vs 31.3 ± 4.9 mm; p < 0.001). During one-year follow-up, no major complication or mortality occured and no reintervention or re-do surgery was undertaken. Ostium secundum atrial septal defect can be closed safely both by surgical and transcatheter method. The surgical treatment has stood the test of time and can be used in all types of atrial defects. However, it has higher incidence of minor complications and longer periods of hospitalisation. Whilst being less invasive, the transcatheter method is more expensive and suitable only for patients with appropriate defect morphology. Both types of defect closure lead to improved function and reduction of right ventricle in mid-term follow-up.

Keywords: atrial septal defect; transcatheter closure; Amplatzer; surgical closure

Received: December 15, 2004; Accepted: February 14, 2005; Published: October 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Růžička P, Malík P, Černý J, Kučera D, Homza M, Kala P, Brychta T. Comparison of catheterisation and surgical treatment of ostium secundum type atrial septal defect in adult patients. Vnitr Lek. 2005;51(10):1079-1086.
Download citation

References

  1. Berger VM, Dahert I, Ewert P et al. Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder. Cardiol Young 2000; 10: 534-537. Go to original source... Go to PubMed...
  2. Black MD, Freedom RM. Minimally invasive repair of atrial septal defects. Ann Thorac Surg 1998; 65: 765-767. Go to original source...
  3. Cowley CG, Lloyd TF, Bove EL et al. Comparison of results of closure of secundum atrial septal defect by surgery versus Amplatzer septal occluder. Am J Cardiol 2001; 88: 589-591. Go to original source... Go to PubMed...
  4. Du ZD, Hijazi ZM, Kleinman CS et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002; 39: 1836-1844. Go to original source... Go to PubMed...
  5. Durongpisitkul K, Soongswang J, Laohaprasitiporn D et al. Comparison of atrial septal defect closure using Amplatzer septal occluder with surgery. Pediatr Cardiol 2002; 23: 36-40. Go to original source... Go to PubMed...
  6. Fischer G, Kramer HH, Stieh J et al. Transcatheter closure of secundum atrial septal defects with the new self-expanding Amplatzer septal occluder. Eur Heart J 1999; 20: 541-549. Go to original source... Go to PubMed...
  7. Formigari R, Di Donato RM, Mazzera E et al. Minimally invasive or interventional repair of atrial septal defects in children: Experience in 171 cases and comparison with conventional strategies. J Am Coll Cardiol 2001; 37: 1707-1712. Go to original source... Go to PubMed...
  8. Harper RW, Mottram PM, McGaw DJ. Closure of secundum atrial septal defects with the Amplatzer septal occluder device: Techniques and problems. Cardiovasc Intervent 2002; 57: 508-524. Go to original source... Go to PubMed...
  9. Hughes ML, Maskell G, Goh TH et al. Prospective comparison of costs and short term health outcomes of surgical versus device closure of atrial septal defect in children. Heart 2002; 88: 67-70. Go to original source... Go to PubMed...
  10. Chan KC, Goodman MJ, Walsh K et al. Transcatheter closure of atrial septal defect and interatrial communications with a new self-expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 1999; 82: 300-306. Go to original source... Go to PubMed...
  11. Chessa M, Carminati M, Butera G et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002; 39: 1061-1065. Go to original source... Go to PubMed...
  12. Khan JH, McElhinney DB, Reddy VM et al. A 5-year experience with surgical repair of atrial septal defect employing limited exposure. Cardiol Young, 1999; 9: 572-576. Go to original source... Go to PubMed...
  13. Masura J, Gavora P, Formanek A et al. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: Initial human experience. Cathet Cardiovasc Diagn 1997; 42: 388-393. Go to original source... Go to PubMed...
  14. Meijboom F, Hess J, Szatmari A et al. Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young age. Am J Cardiol 1993; 72: 1431-1434. Go to original source... Go to PubMed...
  15. Murphy JG, Gersh BJ, Mc Goon MD et al. Long term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990; 323: 1645-1650. Go to original source... Go to PubMed...
  16. Omeish A, Hijazi ZM. Transcatheter closure of atrial septal defects in children & adults using the Amplatzer septal occluder. J Interv Cardiol 2001; 14: 37-44. Go to original source... Go to PubMed...
  17. Popelová J Vrozené srdeční vady v dospělosti. Praha: Grada Publishing 2003.
  18. Tax P, Reich O, Marek J et al. Uzávěr defektu síňového septa Amplatzovou katetrizační technikou. Čs Pediat 2003; 8: 484-491.
  19. Thomson JDR, Aburawi EH, Watterson KG et al. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost. Heart 2002; 87: 466-469. Go to original source... Go to PubMed...
  20. Veselka J, Mates M, Honěk T et al. Dospělí pacienti po operaci defektu septa síní typu ostium primum v dětském věku: echokardiografická studie. Vnitř Lék 2000; 46: 96-101. Go to PubMed...
  21. Waight DJ, Koenig PR, Cao Q et al. Transcatheter closure of secundum atrial septal defects using the Amplatzer Septal Occluder: clinical experience and technical considerations. Curr Intervent Cardiol Rep 2000; 2: 70-77.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.